| RIGL Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the RIGL shares outstanding history going back to 2/23/2010:
Also see: RIGL Market Cap History RIGL YTD Return |
RIGL Shares Outstanding History — Rigel Pharmaceuticals Share Count Over Time
As of 2/25/2026 Rigel Pharmaceuticals has 18.47 million RIGL shares outstanding. Investors often track the RIGL shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows RIGL share count trends over time, with 65 historical shares outstanding datapoints presented, dating back to 2/23/2010.
| RIGL Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RIGL Historical Shares Outstanding: +8.24% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RIGL Stock Price Chart |
| About Rigel Pharmaceuticals Inc |
| Rigel Pharmaceuticals, Inc. is a biotechnology company. Co. is engaged in developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. It is focused on products that address signaling pathways that are critical to disease mechanisms. Its first product is TAVALISSE (fostamatinib disodium hexahydrate) tablets, the approved oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia (ITP) who have had an insufficient response to a previous treatment. We show 65 historical shares outstanding datapoints in our coverage of RIGL's shares outstanding history. Understanding the changing numbers of RIGL shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like RIGL versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching RIGL by allowing them to research RIGL shares outstanding history as well as any other stock in our coverage universe. |
| RIGL Current Stock Quote |
Quotes delayed 20 minutes  Free RIGL Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| RIGL Share Performance |
| Shares Outstanding Peers |
| Rigel Pharmaceuticals (RIGL) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
RLAY Shares Outstanding History RLMD Shares Outstanding History RLYB Shares Outstanding History RMD Shares Outstanding History RMED Shares Outstanding History RMTI Shares Outstanding History RNA Shares Outstanding History RNAC Shares Outstanding History RNAZ Shares Outstanding History RNTX Shares Outstanding History More Healthcare companies » |
RIGL Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
